Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print December 11, 2003, doi: 10.1161/01.RES.0000111521.40760.18
A more recent version of this article appeared on February 6, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/2/201    most recent
01.RES.0000111521.40760.18v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsson, M. C.
Right arrow Articles by Moore, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olsson, M. C.
Right arrow Articles by Moore, R. L.
Related Collections
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies

Submitted on November 20, 2000
Revised on November 20, 2003
Accepted on November 25, 2003

Morphological and Functional Alterations in Ventricular Myocytes From Male Transgenic Mice With Hypertrophic Cardiomyopathy

M. Charlotte Olsson ; Bradley M. Palmer ; Brian L. Stauffer ; Leslie A. Leinwand ; and Russell L. Moore *

From the Department of Integrative Physiology (M.C.O., B.M.P., R.L.M.), Department of Molecular, Cellular, and Developmental Biology (B.L.S., L.A.L), University of Colorado, Boulder, Colo. The present address for M.C.O. is the Department of Neuroscience, Neurophysiology, University of Uppsala, Uppsala, Sweden; and B.M.P. is at the Department of Molecular Physiology and Biophysics, University of Vermont, College of Medicine, Burlington, Vt.

* To whom correspondence should be addressed. E-mail: rmoore{at}spot.colorado.edu.

Familial hypertrophic cardiomyopathy (FHC) is a human genetic disorder caused by mutations in sarcomeric proteins. It is generally characterized by cardiac hypertrophy, fibrosis, and myocyte disarray. A transgenic mouse model of FHC with mutations in the actin-binding domain of the {alpha}-myosin heavy chain (MyHC) gene displays many phenotypes similar to human FHC. At 4 months, male transgenic (TG) mice present with concentric cardiac hypertrophy that progresses to dilation with age. Accompanying this latter morphological change is systolic and diastolic dysfunction. Left ventricular (LV) myocytes from male TG and wild-type (WT) littermates at 5 and 12 months of age were isolated and used for morphological and functional studies. Myocytes from 5- and 12-month-old TG animals had shorter sarcomere lengths compared with WT. This sarcomere length difference was abolished in the presence of 2,3-butanedione monoxime, suggesting that the basal level of contractile element activation was increased in TG myocytes. Myocytes from 12-month-old TG mice were significantly longer than those from age-matched WT controls, and TG myocytes exhibited Z-band disorganization. When cells were paced at 0.5 Hz, TG myocyte relengthening and the fall in intracellular [Ca2+] were slowed when compared with cells from age-matched WT controls. Moreover, an increased amount of {beta}-myosin heavy chain protein was found in hearts from TG compared with WT. Thus, myocytes from the {alpha}-MyHC TG mouse model display many morphological and functional abnormalities that may help explain the LV dysfunction seen in this TG mouse model of FHC.


Key words: 2,3-butanedione monoxime • calcium • relaxation • heart failure




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, Y. Wang, P. Teekakirikul, J. T. Hinson, D. Fatkin, S. Strouse, P. VanBuren, C. E. Seidman, J. G. Seidman, and D. W. Maughan
Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1939 - H1947.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Kabaeva, M. Zhao, and D. E. Michele
Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1667 - H1674.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. E. Bondarenko and R. L. Rasmusson
Simulations of propagated mouse ventricular action potentials: effects of molecular heterogeneity
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1816 - H1832.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. E. Mueller, S. A. Grandy, and S. E. Howlett
Protein Kinase A-Mediated Phosphorylation Contributes to Enhanced Contraction Observed in Mice That Overexpress beta-Adrenergic Receptor Kinase-1
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1307 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Richard, E. Villard, P. Charron, and R. Isnard
The Genetic Bases of Cardiomyopathies
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
L. T. Izu, S. A. Means, J. N. Shadid, Y. Chen-Izu, and C. W. Balke
Interplay of Ryanodine Receptor Distribution and Calcium Dynamics
Biophys. J., July 1, 2006; 91(1): 95 - 112.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. P. Konhilas, P. A. Watson, A. Maass, D. M. Boucek, T. Horn, B. L. Stauffer, S. W. Luckey, P. Rosenberg, and L. A. Leinwand
Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy
Circ. Res., March 3, 2006; 98(4): 540 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Emter, S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore
Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2030 - H2038.
[Abstract] [Full Text] [PDF]